BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35623780)

  • 1. Widely quasi-quantitative analysis enables temporal bile acids-targeted metabolomics in rat after oral administration of ursodeoxycholic acid.
    Cao Y; Li W; Gong X; Niu X; Zheng J; Yu J; Li J; Tu P; Song Y
    Anal Chim Acta; 2022 Jun; 1212():339885. PubMed ID: 35623780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids.
    Yang T; Shu T; Liu G; Mei H; Zhu X; Huang X; Zhang L; Jiang Z
    J Steroid Biochem Mol Biol; 2017 Sep; 172():69-78. PubMed ID: 28583875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squared Energy-Resolved Mass Spectrometry Advances Quantitative Bile Acid Submetabolome Characterization.
    Cao Y; Li W; Chen W; Niu X; Wu N; Wang Y; Li J; Tu P; Zheng J; Song Y
    Anal Chem; 2022 Nov; 94(44):15395-15404. PubMed ID: 36286389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serially coupled reversed phase-hydrophilic interaction liquid chromatography-tailored multiple reaction monitoring, a fit-for-purpose tool for large-scale targeted metabolomics of medicinal bile.
    Song Q; Liu W; Chen X; Li J; Li P; Yang F; Wang Y; Song Y; Tu P
    Anal Chim Acta; 2018 Dec; 1037():119-129. PubMed ID: 30292285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust and Comprehensive Targeted Metabolomics Method for Quantification of 50 Different Primary, Secondary, and Sulfated Bile Acids in Multiple Biological Species (Human, Monkey, Rabbit, Dog, and Rat) and Matrices (Plasma and Urine) Using Liquid Chromatography High Resolution Mass Spectrometry (LC-HRMS) Analysis.
    Sangaraju D; Shi Y; Van Parys M; Ray A; Walker A; Caminiti R; Milanowski D; Jaochico A; Dean B; Liang X
    J Am Soc Mass Spectrom; 2021 Aug; 32(8):2033-2049. PubMed ID: 33826317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-, age-, and organ-dependent improvement of bile acid hydrophobicity by ursodeoxycholic acid treatment: A study using a mouse model with human-like bile acid composition.
    Ueda H; Honda A; Miyazaki T; Morishita Y; Hirayama T; Iwamoto J; Nakamoto N; Ikegami T
    PLoS One; 2022; 17(7):e0271308. PubMed ID: 35819971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
    Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
    J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chemical derivatization-based pseudotargeted liquid chromatography-tandem mass spectrometry method for sensitive and high coverage determination of bile acids in human serum.
    Xiong X; Gu X; Li X; Jia K; Wei Y; Zhao R
    Anal Chim Acta; 2024 Jan; 1287():342119. PubMed ID: 38182391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic acid accelerates bile acid enterohepatic circulation.
    Zhang Y; Jiang R; Zheng X; Lei S; Huang F; Xie G; Kwee S; Yu H; Farrar C; Sun B; Zhao A; Jia W
    Br J Pharmacol; 2019 Aug; 176(16):2848-2863. PubMed ID: 31077342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice.
    Fu ZD; Klaassen CD
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):680-90. PubMed ID: 24183703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the pool of bile acids in hepatocyte nuclei during rat liver regeneration.
    Monte MJ; Martinez-Diez MC; El-Mir MY; Mendoza ME; Bravo P; Bachs O; Marin JJ
    J Hepatol; 2002 Apr; 36(4):534-42. PubMed ID: 11943426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Widely quasi-quantitative analysis of both metabolites and tryptic peptides in animal-originated medicinal materials: Bufonis Venenum as a case.
    Li W; Liao Y; Hong Q; Li H; Cao Y; Chen W; Liu J; Tu P; Li J; Song Y
    J Pharm Biomed Anal; 2023 Jan; 223():115143. PubMed ID: 36368132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
    Chen W; Wei Y; Xiong A; Li Y; Guan H; Wang Q; Miao Q; Bian Z; Xiao X; Lian M; Zhang J; Li B; Cao Q; Fan Z; Zhang W; Qiu D; Fang J; Gershwin ME; Yang L; Tang R; Ma X
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):25-38. PubMed ID: 30900136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.
    Munoz-Garrido P; Marin JJ; Perugorria MJ; Urribarri AD; Erice O; Sáez E; Úriz M; Sarvide S; Portu A; Concepcion AR; Romero MR; Monte MJ; Santos-Laso Á; Hijona E; Jimenez-Agüero R; Marzioni M; Beuers U; Masyuk TV; LaRusso NF; Prieto J; Bujanda L; Drenth JP; Banales JM
    J Hepatol; 2015 Oct; 63(4):952-61. PubMed ID: 26044126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinatal exposure to UDCA prevents neonatal cholestasis in Cyp2c70
    de Vries HD; Palmiotti A; Li R; Hovingh MV; Mulder NL; Koehorst M; Bloks VW; van Zutphen T; Kuipers F; de Boer JF
    Pediatr Res; 2023 May; 93(6):1582-1590. PubMed ID: 36151295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbially catalyzed conjugation of GABA and tyramine to bile acids.
    Mullowney MW; Fiebig A; Schnizlein MK; McMillin M; Rose AR; Koval J; Rubin D; Dalal S; Sogin ML; Chang EB; Sidebottom AM; Crosson S
    J Bacteriol; 2024 Jan; 206(1):e0042623. PubMed ID: 38174933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The profile of bile acids and their sulfate metabolites in human urine and serum.
    Bathena SP; Mukherjee S; Olivera M; Alnouti Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 942-943():53-62. PubMed ID: 24212143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of human C24 bile acids metabolome in serum and urine based on enzyme digestion of conjugated bile acids and LC-MS determination of unconjugated bile acids.
    Zhu P; Zhang J; Chen Y; Yin S; Su M; Xie G; Brouwer KLR; Liu C; Lan K; Jia W
    Anal Bioanal Chem; 2018 Aug; 410(21):5287-5300. PubMed ID: 29907951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acids metabonomic study on the CCl4- and alpha-naphthylisothiocyanate-induced animal models: quantitative analysis of 22 bile acids by ultraperformance liquid chromatography-mass spectrometry.
    Yang L; Xiong A; He Y; Wang Z; Wang C; Wang Z; Li W; Yang L; Hu Z
    Chem Res Toxicol; 2008 Dec; 21(12):2280-8. PubMed ID: 19053324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Metabolic Correlations of Ursodeoxycholic Acid with Other Bile Acid Species through In Vitro Sequential Metabolism and Isomer-Focused Identification.
    Li W; Chen W; Niu X; Zhao C; Tu P; Li J; Liu W; Song Y
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.